4559:TYO
Zeria Pharmaceutical Co Ltd
JP¥2.292,00
arrow_upward
+0,97%(+22,00) 1D
29 ພ.ພ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
JP¥2.270
High
JP¥2.292
Low
JP¥2.267
Mkt. cap
໑໑໔,໘໗ ຕື້
Avg. vol.
໙໔,໒໗ ພັນ
Volume
໑໕໐,໐໐ ພັນ
Dividend
໒,໑໔%
Quarterly dividend
JP¥12
Ex-dividend date
29 ກ.ຍ. 2025
P/E ratio
໑໑,໙໕
52-wk high
JP¥2.434
52-wk low
JP¥1.878
EPS
JP¥192
Shares outstanding
໕໐,໑໑ ລ້ານ
No. of employees
໒ ພັນ
Open
JP¥2.270
High
JP¥2.292
Low
JP¥2.267
Mkt. cap
໑໑໔,໘໗ ຕື້
Avg. vol.
໙໔,໒໗ ພັນ
Volume
໑໕໐,໐໐ ພັນ
Dividend
໒,໑໔%
Quarterly dividend
JP¥12
Ex-dividend date
29 ກ.ຍ. 2025
P/E ratio
໑໑,໙໕
52-wk high
JP¥2.434
52-wk low
JP¥1.878
EPS
JP¥192
Shares outstanding
໕໐,໑໑ ລ້ານ
No. of employees
໒ ພັນ
News stories
From sources across the web
Simply Wall Street
·
56 ນາທີກ່ອນ
Opendoor Tests AI Mortgage Platform As It Seeks Broader Housing Role
Yahoo Finance
·
7 ຊົ່ວໂມງກ່ອນ
This Unstoppable Vanguard ETF Has More Than Doubled the S&P 500 in the Last 10 Years. Could It Make You a Millionaire?
CNBC
·
13 ຊົ່ວໂມງກ່ອນ
Berkshire trails red-hot S&P 500 by biggest margin so far this year
Investor's Business Daily
·
2 ຊົ່ວໂມງກ່ອນ
Deal Or No Deal, Stocks Still Run. Five Titans Near Buy Points.
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1,75 ພັນ
Founded22 ທ.ວ. 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp
AI content may include mistakes. Learn more